Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 1999

View Archived Issues

Pharmacopeia to provide lead discovery services to Roche Bioscience

Abelcet approved in Belgium

Repligen receives SBIR grants to support discovery of novel active compounds

Atairgin and Northwestern University to collaborate on ovarian cancer diagnostic

Corvas enters rNAPc2 manufacturing agreement in anticipation of phase III trials

Synsorb Biotech's second quarter marked by progress in clinical trials

Alcon introduces ocular antiinflammatory agent in Germany

Hoechst Marion Roussel establishes three high-priority compounds during Q2 1999

Nabi reports positive interim results from Nabi-StaphVAX pivotal trial

Aradigm presents data on morphine electronic inhaler at pain congress in Vienna

Highly stable and lipophilic camptothecin derivatives prepared at Tigen

Ferriprox approved in Europe as second-line thalassemia therapy

The aging heart: Should we refine management?

Clinical candidate selected from 5-ht6 receptor antagonist program at Roche

ACS news flash: Agouron investigates CDK inhibitors as anticancer agents

Australian academic-industrial team identifies improved opioid analgesics

General Hospital Corp. discloses DNA vaccine for preventing, treating hepatitis C

Fujisawa prepares novel series of vasopressin antagonists

More selective GABA-A receptor ligands prepared and evaluated at Merck & Co.

University of Minnesota team describes potent and selective kappa-opioid antagonist at ACS

Institute for Diabetes Discovery researchers synthesize an improved aldose reductase inhibitor

Temodal approved in E.U. for treatment of recurrent anaplastic astrocytoma

Cell Pathways seeks approval of Aptosyn in the U.S.

ACS presentation for PD-176078, a novel calcium channel blocker with analgesic activity

Double prodrug UR-3216, a potent, long-lasting and orally active gpIIb/IIIa antagonist

SR-123781A, a novel heparin mimetic with advantages over standard heparin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026